Cargando…
Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy
Myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2) are multisystem, genetic disorders caused by repeat expansions on chromosome 19 (DM1) and chromosome 3 (DM2). Although the effects of DM on the skeletal, cardiac, and smooth muscles, as well as the endocrine and central nervous syst...
Autor principal: | White, Molly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458891/ https://www.ncbi.nlm.nih.gov/pubmed/31970692 http://dx.doi.org/10.1007/s43441-020-00117-3 |
Ejemplares similares
-
Learnings from Patient-Report Workshop on Disease Progression in Myotonic Dystrophy
por: White, Molly
Publicado: (2019) -
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1
por: Simoncini, Costanza, et al.
Publicado: (2020) -
Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1
por: Nakamori, Masayuki, et al.
Publicado: (2022) -
Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight
por: Hamilton, Mark J., et al.
Publicado: (2018) -
Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1)
por: Rossi, Salvatore, et al.
Publicado: (2023)